China Healthcare Weekly (Aug.13)
The insight analyzed the VBP of Chinese patent medicine, market concerns on centralized procurement of medical equipment, and necessary conditions...
226 Views
Pre-IPO Asymchem Laboratories - The Strength and the Concerns
The article mainly analyzed Asymchem Laboratories in terms of the industry characteristics, the strength of its business, the comparison with...
281 Views
Asymchem Labs A/H Listing Early Look - Fast Growing, Relatively Insulated
Asymchem Laboratories (002821 CH) (AL) aims to raise around US$1-1.5bn in its H-share listing in Hong Kong. The A-shares listed were listed in...
220 Views
Wuxi Biologics Placement - Similar Deal Will Yield Similar Results
Wuxi Biologics Holdings is looking to raise up to US$1.3bn by selling about 1.8% of Wuxi Biologics (2269 HK). This is the company's 15th placement...
365 Views
HCM Secondary Trading: NPMA Approvals Warrant a Pop on Debut
We look updates from HCM since it launched its book building. We note that the recent NMPA approval will result in a share price pop on debut.
209 Views